Nabriva Therapeutics Plc Asset Turnover Ratio (NBRV), as of second quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Nabriva Therapeutics Plc  (NASDAQ: NBRV)
 

Nabriva Therapeutics Plc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Nabriva Therapeutics Plc's asset turnover ratio, the ratio that measures the ability of Nabriva Therapeutics Plc's assets to generate revenue, sequentially decreased to 0.53 in the second quarter (Jun 30 2023), which does not come as a surprise, as the Nabriva Therapeutics Plc continue to experience difficult business climate.

Within sector 187 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Second Quarter 2023 compared to the preceding quarter from 3351 to 3353.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NBRV Asset Turnover Ratio (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Asset Change -73.85 % -52.42 % -23.53 % -57.27 % -53.06 %
Y / Y Revenue Change -75.6 % -5.36 % 14.15 % 3.28 % 11.5 %
Asset Turnover Ratio (TTM) 0.53 0.58 0.53 0.43 0.38
NBRV's Total Ranking # 3353 # 3351 # 3351 # 2834 # 2518
Seq. Asset Change -56.54 % -84.42 % 391.06 % -21.38 % -20.9 %
Seq. Revenue Change -70.45 % -28.2 % 15.49 % -0.41 % 14.6 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 188
Healthcare Sector # 529
Overall Market # 3353

Asset Turnover Ratio Statistics
High Average Low
3.48 2.06 0.6
(Mar 31 2023)   (Jun 30 2019)




NBRV Company Profile • Back to NBRV Efficiency Comparisons • Compare NBRV Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2023 Assets at quarter ending Jun 30 2023
American Oncology Network Inc   6.82 $ 1,216.420  Millions$ 178.366  Millions
Longduoduo Co Ltd  4.46 $ 3.819  Millions$ 0.856  Millions
Lifemd Inc   3.96 $ 127.125  Millions$ 32.086  Millions
Lifevantage Corp  3.14 $ 213.011  Millions$ 67.878  Millions
Wearable Health Solutions, Inc.  3.02 $ 0.745  Millions$ 0.247  Millions
Escalon Medical Corp   2.44 $ 12.180  Millions$ 4.999  Millions
Scienture Holdings Inc   2.33 $ 9.443  Millions$ 4.046  Millions
Healthcare Services Group Inc   2.29 $ 1,674.669  Millions$ 730.347  Millions
Patterson Companies Inc   2.25 $ 6,524.261  Millions$ 2,896.309  Millions
Aridis Pharmaceuticals Inc   2.09 $ 22.341  Millions$ 10.683  Millions
Interpace Biosciences Inc   2.08 $ 32.771  Millions$ 15.773  Millions
Sunlink Health Systems Inc   1.93 $ 48.489  Millions$ 25.173  Millions
Integrated Biopharma Inc  1.91 $ 50.061  Millions$ 26.182  Millions
Hims and Hers Health Inc   1.87 $ 709.967  Millions$ 378.840  Millions
Nature s Sunshine Products inc   1.87 $ 431.513  Millions$ 231.006  Millions
Agilon Health Inc   1.81 $ 3,669.831  Millions$ 2,022.773  Millions
Kewaunee Scientific Corporation  1.80 $ 218.285  Millions$ 121.155  Millions
Privia Health Group Inc   1.77 $ 1,506.950  Millions$ 853.379  Millions
Mimedx Group Inc   1.71 $ 294.997  Millions$ 172.191  Millions
Rockwell Medical inc   1.67 $ 74.722  Millions$ 44.833  Millions
Encision Inc   1.64 $ 6.848  Millions$ 4.183  Millions
Vycor Medical Inc   1.61 $ 1.425  Millions$ 0.888  Millions
Progyny Inc   1.60 $ 956.727  Millions$ 596.173  Millions
Champions Oncology Inc   1.55 $ 52.686  Millions$ 33.990  Millions
Cano Health Inc   1.53 $ 2,978.861  Millions$ 1,944.191  Millions
Chemed Corporation  1.53 $ 2,187.099  Millions$ 1,433.643  Millions
International Stem Cell Corporation  1.51 $ 8.060  Millions$ 5.326  Millions
Biofrontera Inc   1.51 $ 69.770  Millions$ 46.203  Millions
Henry Schein Inc   1.45 $ 12,598.000  Millions$ 8,714.750  Millions
Zynex inc   1.43 $ 177.447  Millions$ 123.882  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.